Open original FDA record ↗Recall record
- FDA identifier
- Z-0820-2022
- Company in FDA record
- Baxter Healthcare Corporation
- FDA record creation date
- Mar 23, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential damage to the power cord may cause the power conductors to be exposed, thereby creating a risk of shock from the power mains.
Source facts
- Action
- Customer notification letters were mailed beginning 02/21/2022. A localized customer letter will be mailed (with signature service) to all first-level consignees by Sedgwick. The letter will inform the customer of the issue, reason for Field Action and provide risk mitigations. The customer will be instructed to sign acknowledgement form to confirm receipt and return to a dedicated email address. Distributors will be asked to forward to their end users. Distributors will be provided with instructions on communication with their end users. All consignees will be required to return a signed acknowledgment form and confirm that they read and understand the issue. Distributors will be asked to forward to their end users. Distributors will be provided instruction on communication with their end users.
- Initiated
- 2022-02-14
- Root cause
- Labeling design
- Terminated
- 2026-07-02
- Distribution
- Worldwide distribution - US Nationwide and the countries of Australia, Austria, Bahamas, Bahrain, Belgium, Bermuda, Brazil, Cameroon, Canada, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, India, Ireland, Italy, Jamaica, Jordan, Kuwait, Mexico, Netherlands, New Zealand, Norway, Oman, Poland, Qatar, Romania, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Thailand, Turkmenistan, UAE, and UK.
- Recall number
- Z-0820-2022
- Recall status
- Terminated
- CDRH record ID
- 192099
- FDA record created
- 2022-03-23
- Recall event number
- 89644